First Mercantile Trust’s Amneal Pharmaceuticals AMRX Stock Holding History

First Mercantile Trust’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,960	Closed	-$79K	–	906
2019 Q2	$79K	Sell	10,960 -972	-8%	-$9.94K	0.01%	695
2019 Q1	$169K	Buy	11,932 +3,461	+41%	+$45.7K	0.04%	514
2018 Q4	$115K	Sell	8,471 -609	-7%	-$11K	0.03%	607
2018 Q3	$201K	Sell	9,080 -386	-4%	-$8.12K	0.04%	512
2018 Q2	$155K	Buy	+9,466	New	+$166K	0.03%	582

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

First Mercantile Trust's AMRX Position: Q3 2019 in Review

First Mercantile Trust sold out of Amneal Pharmaceuticals (AMRX) in Q3 2019, closing a stake of 10,960 shares — an estimated $79K sold.

First Mercantile Trust first reported a position in AMRX in Q2 2018 and held it in 5 quarters. The position peaked at $201K in Q3 2018. 121 funds tracked by Wall St. Rank hold AMRX as of Q3 2019.

First Mercantile Trust reported no remaining Amneal Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
First Mercantile Trust sold 10,960 Amneal Pharmaceuticals shares in Q3 2019, an estimated $79K.
First Mercantile Trust first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 5 quarters.
First Mercantile Trust's Amneal Pharmaceuticals position peaked at $201K in Q3 2018.
121 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2019.

Based on First Mercantile Trust's 13F filing for Q3 2019, filed 1 Nov 2019.